Are monoaminergic systems involved in the lethargy induced by a parasitoid wasp in the cockroach prey?
The venom of the parasitoid wasp Ampulex compressa induces long-lasting hypokinesia in the cockroach prey. Previous work indicates that the venom acts in the subesophageal ganglion to indirectly affect modulation of thoracic circuits for locomotion. However, the target of the venom in the subesophageal ganglion, and the mechanism by which the venom achieves its effects are as yet unknown. While the stung cockroaches appear generally lethargic, not all behaviors were affected, indicating that the venom targets specific motor systems and not behavior in general. Stung cockroaches were observed "freezing" in abnormal positions. Reserpine, which depletes monoamines, mimics the behavioral effects of the venom. We treated cockroaches with antagonists to dopamine and octopamine receptors, and found that the dopamine system is required for normal escape response. Dopamine injection induces prolonged grooming in normal cockroaches, but not in stung, suggesting that the venom is affecting dopamine receptors, or targets downstream of these receptors, in the subesophageal ganglion. This dopamine blocking effect fades slowly over the course of several weeks, similar to the time course of recovery from hypokinesia. The similarity in the time courses suggests that the mechanism underlying the hypokinesia may be the block of the dopamine receptors.
Weisel-Eichler
A
A
Department of Life Sciences and Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, Beer Sheva, Israel. aviva@alum.mit.edu
Libersat
F
F
D018759:Adrenergic Uptake Inhibitors / Q000494:pharmacology; D000704:Analysis of Variance; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D015306:Biogenic Monoamines / Q000494:pharmacology* / Q000502:physiology; D003058:Cockroaches / Q000469:parasitology / Q000502:physiology*; D004298:Dopamine / Q000494:pharmacology / Q000502:physiology; D018492:Dopamine Antagonists / Q000494:pharmacology; D005260:Female; D005475:Flupenthixol / Q000494:pharmacology; D008297:Male; D008803:Mianserin / Q000494:pharmacology; D008954:Models, Biological; D009043:Motor Activity / Q000187:drug effects / Q000502:physiology; D011954:Receptors, Dopamine / Q000502:physiology*; D012110:Reserpine / Q000494:pharmacology; D012702:Serotonin Antagonists / Q000494:pharmacology; D013997:Time Factors; D014862:Wasp Venoms / Q000494:pharmacology; D014863:Wasps / Q000254:growth & development*
D018759:Adrenergic Uptake Inhibitors; D015306:Biogenic Monoamines; D018492:Dopamine Antagonists; D011954:Receptors, Dopamine; D012702:Serotonin Antagonists; D014862:Wasp Venoms; D008803:Mianserin; D012110:Reserpine; D005475:Flupenthixol; D004298:Dopamine